Skip to main content

Neuraxis, INC

NRXS
Exchange
NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0001933567

No open-market purchases or sales by Neuraxis, INC insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $19.2M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +6 vs. previous quarter
32
13F valueReported value at the end of Q2 2026
$19.2M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding NRXS, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding NRXS at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Neuraxis, INC insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 3, 2026 (view filing)Apr 12 daysHenrichs Timothy RobertChief Financial OfficerPPurchase+7.59K$1.96+$14.9KNew position7.59K after
Apr 3, 2026 (view filing)Apr 12 daysCarrico Thomas JoesephCRO, CCO, CPOPPurchase+667$1.96+$1.31K+0.2%331.9K after
Apr 3, 2026 (view filing)Apr 12 daysCarrico Brian AllenChief Executive OfficerPPurchase+8.06K$1.96+$15.8K+2.4%348.2K after
Feb 13, 2026 (view filing)Feb 11-122 daysHannasch Brian10% OwnerPPurchase+80.0K$4.79+$382.8K+7.1%1.21M after2 lots
Dec 29, 2025 (view filing)Dec 236 daysAharon GilDirectorPPurchase+286.1K$3.52+$1.01MNew position286.1K after
Jul 3, 2025 (view filing)Jul 12 daysHannasch Brian10% OwnerPPurchase+355.6K$2.25+$800.0K+45.8%1.13M after
Jul 3, 2025 (view filing)Jul 12 daysMasimo Corp10% OwnerSSale−821.3K$2.25−$1.85M−100.0%0 after2 lots
Apr 23, 2025 (view filing)Apr 212 daysHannasch Brian10% OwnerPPurchase+18.1K$1.73+$31.3K+2.4%776.0K after
Jan 23, 2024 (view filing)4:06 PM ETDec 28, 202326 daysLateHannasch Brian10% OwnerSSale−76$2.61−$198.360.0%532.9K after

Top 10 13F holders, Q2 2026

The largest institutional positions in Neuraxis, INC at the end of Q2 2026; share changes are against Q1 2026.

See all 32 holders
Institutions holding NRXS in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
AIGH Capital Management LLC519,938$3.80M0.34%+119,938+30.0%Added
Rosalind Advisors, Inc.508,055$2.97M1.12%+221,917+77.6%Added
Vanguard Capital Management LLC335,793$2.45M0.00%+109,926+48.7%Added
Money Concepts Capital Corp228,029$1.67M0.08%+2,474+1.1%Added
Renaissance Technologies LLC169,400$1.24M0.00%+92,446+120.1%Added
Marshall Wace, LLP128,755$941.2K0.00%+50,060+63.6%Added
Parsons Capital Management Inc117,808$861.2K0.04%+1,082+0.9%Added
Panoramic Capital, LLC115,000$840.6K0.36%−75,000−39.5%Reduced
Geode Capital Management, LLC96,361$704.7K0.00%+3,256+3.5%Added
Citadel Advisors LLC85,053$621.7K0.00%+85,053New